119 related articles for article (PubMed ID: 22841862)
1. Single intravenous low-dose injections of connexin 43 mimetic peptides protect ischemic heart in vivo against myocardial infarction.
Hawat G; Hélie P; Baroudi G
J Mol Cell Cardiol; 2012 Oct; 53(4):559-66. PubMed ID: 22841862
[TBL] [Abstract][Full Text] [Related]
2. Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury.
Hawat G; Benderdour M; Rousseau G; Baroudi G
Pflugers Arch; 2010 Aug; 460(3):583-92. PubMed ID: 20514543
[TBL] [Abstract][Full Text] [Related]
3. Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43.
Wu Y; Gu EW; Zhu Y; Zhang L; Liu XQ; Fang WP
Int Immunopharmacol; 2012 Jul; 13(3):341-6. PubMed ID: 22561119
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of connexin43 improves functional recovery after ischemic brain injury in neonatal rats.
Li X; Zhao H; Tan X; Kostrzewa RM; Du G; Chen Y; Zhu J; Miao Z; Yu H; Kong J; Xu X
Glia; 2015 Sep; 63(9):1553-67. PubMed ID: 25988944
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
6. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
7. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
8. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening.
Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L
Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term effects of melatonin on myocardial post-ischemic recovery.
Lochner A; Genade S; Davids A; Ytrehus K; Moolman JA
J Pineal Res; 2006 Jan; 40(1):56-63. PubMed ID: 16313499
[TBL] [Abstract][Full Text] [Related]
10. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on ischemia and reperfusion-induced myocardial infarction in rats and dogs.
Oh KS; Seo HW; Yi KY; Lee S; Yoo SE; Lee BH
Fundam Clin Pharmacol; 2007 Jun; 21(3):255-63. PubMed ID: 17521294
[TBL] [Abstract][Full Text] [Related]
11. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
12. The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury.
Xu D; Li Y; Wang J; Davey AK; Zhang S; Evans AM
Life Sci; 2007 Jan; 80(4):269-74. PubMed ID: 17055001
[TBL] [Abstract][Full Text] [Related]
13. Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevation.
Wang N; De Bock M; Antoons G; Gadicherla AK; Bol M; Decrock E; Evans WH; Sipido KR; Bukauskas FF; Leybaert L
Basic Res Cardiol; 2012 Nov; 107(6):304. PubMed ID: 23095853
[TBL] [Abstract][Full Text] [Related]
14. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
Inagaki K; Begley R; Ikeno F; Mochly-Rosen D
Circulation; 2005 Jan; 111(1):44-50. PubMed ID: 15611364
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of emulsified isoflurane on myocardial ischemia and reperfusion injury in rats.
Hu ZY; Luo NF; Liu J
Can J Anaesth; 2009 Feb; 56(2):115-25. PubMed ID: 19247759
[TBL] [Abstract][Full Text] [Related]
18. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
Salloum FN; Ockaili RA; Wittkamp M; Marwaha VR; Kukreja RC
J Mol Cell Cardiol; 2006 Mar; 40(3):405-11. PubMed ID: 16480739
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
20. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
